The FDA’s Vaccines and Related Biological Products Advisory Committee has unanimously backed Moderna’s mRNA-based flu shot, ...

Moderna received a unanimous advisory committee vote supporting mRNA-1010, its flu vaccine, for adults 50 and older. Read ...

Moderna ( MRNA 1.03%) has been on fire this year. As of this writing, the company's shares have slightly more than doubled to ...

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large ...

The iShares Morningstar Small-Cap Value ETF (ISCV) carries a lower expense ratio of 0.06% compared to 0.24% for the iShares Russell 2000 Value ETF (IWN). ISCV's 1.88% dividend yield is higher than IWN ...

Cancer treatment is undergoing one of the most significant transformations in modern medical history. For decades, physicians relied primarily on surgery, radiation, and chemotherapy. While those ...

Researchers have identified "DNA switches" that become active as honeybee larvae grow into worker bees, offering new insight ...

Researchers have identified "DNA switches" that become active as honeybee larvae grow into worker bees, offering new insight ...

As you might have read in some of my past articles, when it comes to Barchart, I was a “long time listener, first time caller.”When I started writing here early last year, it was a case of “long time ...

Moderna (MRNA) stock and Capricor Therapeutics (CAPR) stock are in focus as the firms look to benefit from policy reversals ...

Stock Market Today (June 26, 2026): Nasdaq and S&P 500 claw back to gains amid tech sell-off, reported OpenAI IPO delay ...

Moderna just received fantastic news.